INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/Option exerciseVerified data

Perriman Damien Alan reported EXOZ

Chief Commercial Officer · EXOZYMES INC. · EXOZYMES INC. — Restricted Stock Unit

Side
M
Value
—
Shares
3,922
Price
—
Executed
Oct 9, 2026
Disclosed
Oct 26, 2026
Disclosure timeline17 days from execution to publication · legal deadline 2 business days
Oct 9 executedOct 26, 2026 disclosed

EXOZ · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
23/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+5 / 25

No reported dollar value · 11.1% of prior position

  • Filing timing+10 / 15

    Disclosed 11 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · EXOZ

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    23
    PA
    Perriman Damien AlanChief Commercial Officer
    EXOZEXOZYMES INC.
    Option exercise
    		M—
    3,922 sh
    		Oct 9, 2026Oct 26, 2026
    traded Oct 9, 2026
    		+17dSEC FORM 4

    Evidence

    35
    PA
    Perriman Damien AlanChief Commercial Officer
    EXOZEXOZYMES INC.
    Open-market sale
    		SELL$19K
    3,729 sh
    		Oct 12, 2026Oct 26, 2026
    traded Oct 12, 2026
    		+14dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001493152-26-048493
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Oct 9, 2026
    Published
    Oct 26, 2026
    Ingested by INSIDER
    Nov 5, 02:09 UTC
    Last re-read
    Nov 5, 02:09 UTC

    Extracted facts

    Filer
    Perriman Damien Alan
    Role
    Chief Commercial Officer
    Transaction
    Option exerciseAs filed: “M”
    Asset
    EXOZYMES INC. — Restricted Stock Unit
    Ticker
    EXOZ
    Shares
    3,922
    Price per share
    $0
    Execution date (reported)
    Oct 9, 2026
    Owned after transaction
    39.2K shares
    Days from execution to publication
    17

    What this establishes

    Perriman Damien Alan filed this Form 4 reporting a option exercise of EXOZ on Oct 9, 2026. It became public on Oct 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Commercial Officer
    Perriman Damien Alancik:0002096714
    Issuer
    EXOZYMES INC.cik:0002010788

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.